Literature DB >> 2178200

Detection of hepatitis C virus cDNA sequence by the polymerase chain reaction in hepatocellular carcinoma tissues.

T Yoneyama1, K Takeuchi, Y Watanabe, H Harada, A Ohbayashi, Y Tanaka, T Yuasa, I Saito, T Miyamura.   

Abstract

We found the presence of hepatitis C virus (HCV) infection in liver tissues of hepatocellular carcinoma (HCC) patients who had antibodies to HCV but no serological markers for hepatitis B virus infection by the sensitive reverse transcription/polymerase chain reaction (R/PCR) method. The primers used were derived from the non-structural (NS) 3 and/or the structural (C/E) region. Amplified cDNA sequences of HCV were detected in either cancerous or non-cancerous portion of liver tissues from four out of eight HCC patients with primers of NS3 region. Similar but less efficient results were obtained with primers of C/E region. These results indicate that HCV persists in the liver tissue of HCC. A possible role of persistent infection of HCV for the development of HCC is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2178200     DOI: 10.7883/yoken1952.43.89

Source DB:  PubMed          Journal:  Jpn J Med Sci Biol        ISSN: 0021-5112


  3 in total

1.  Discrimination of hepatitis C virus in liver tissues from different patients with hepatocellular carcinomas by direct nucleotide sequencing of amplified cDNA of the viral genome.

Authors:  W H Chou; T Yoneyama; K Takeuchi; H Harada; I Saito; T Miyamura
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

2.  Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma.

Authors:  J Bukh; R H Miller; M C Kew; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

3.  Hepatitis C virus replication is associated with expression of transforming growth factor-alpha and insulin-like growth factor-II in cirrhotic livers.

Authors:  S Tanaka; K Takenaka; T Matsumata; R Mori; K Sugimachi
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.